K-BASKET, TAS-117, PI3K/AKT Gene Aberration
NCT03017521
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
TAS-117
Sponsor
Yonsei University